首页> 外文OA文献 >A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma
【2h】

A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma

机译:基于血浆染色体拷贝数变化检测早期结直肠癌的一种新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/Aims: Colonoscopy screening has been accepted broadly to evaluate the risk and incidence of colorectal cancer (CRC) during health examination in outpatients. However, the intrusiveness, complexity and discomfort of colonoscopy may limit its application and the compliance of patients. Thus, more reliable and convenient diagnostic methods are necessary for CRC screening. Genome instability, especially copy-number variation (CNV), is a hallmark of cancer and has been proved to have potential in clinical application. Methods: We determined the diagnostic potential of chromosomal CNV at the arm level by whole-genome sequencing of CRC plasma samples (n = 32) and healthy controls (n = 38). Arm level CNV was determined and the consistence of arm-level CNV between plasma and tissue was further analyzed. Two methods including regular z score and trained Support Vector Machine (SVM) classifier were applied for detection of colorectal cancer. Results: In plasma samples of CRC patients, the most frequent deletions were detected on chromosomes 6, 8p, 14q and 1p, and the most frequent amplifications occurred on chromosome 19, 5, 2, 9p and 20p. These arm-level alterations detected in plasma were also observed in tumor tissues. We showed that the specificity of regular z score analysis for the detection of colorectal cancer was 86.8% (33/38), whereas its sensitivity was only 56.3% (18/32). Applying a trained SVM classifier (n = 40 in trained group) as the standard to detect colorectal cancer relevance ratio in the test samples (n = 30), a sensitivity of 91.7% (11/12) and a specificity 88.9% (16/18) were finally reached. Furthermore, all five early CRC patients in stages I and II were successfully detected. Conclusion: Trained SVM classifier based on arm-level CNVs can be used as a promising method to screen early-stage CRC.
机译:背景/目的:结肠镜检查筛查已被广泛接受,以评估关门剂健康检查期间结肠直肠癌(CRC)的风险和发病率。然而,结肠镜检查的血液性,复杂性和不适可能限制其应用和患者的依从性。因此,CRC筛选需要更可靠和方便的诊断方法。基因组不稳定性,特别是拷贝数变异(CNV),是癌症的标志,并已被证明具有临床应用的潜力。方法:通过CRc等离子体样品(n = 32)和健康对照(n = 38),确定通过全基因组测序的臂水平染色体CNV的诊断潜力。确定臂水平CNV,进一步分析了血浆和组织之间的臂水平CNV的一致性。将包括常规Z分数和培训的支持向量机(SVM)分类剂在内的两种方法用于检测结直肠癌。结果:在CRC患者的血浆样本中,在染色体6,8P,14Q和1P上检测到最常见的缺失,并且在染色体19,5,2,9P和20P上发生最常见的扩增。在肿瘤组织中也观察到血浆中检测到的这些臂水平改变。我们表明,常规Z分数分析对结直肠癌的定期分析为86.8%(33/38),而其敏感性仅为56.3%(18/32)。将训练的SVM分类器(N = 40在培训的群体中)作为检测测试样品中的结肠直肠癌相关性的标准(n = 30),灵敏度为91.7%(11/12),特异性为88.9%(16 / 18)终于达到了。此外,成功地检测到阶段I和II的所有五名早期CRC患者。结论:基于ARM级CNV的训练SVM分类器可用作筛选早期CRC的有希望的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号